StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report issued on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Down 2.6 %
Shares of NASDAQ:AEZS opened at $3.80 on Friday. Aeterna Zentaris has a 52-week low of $3.96 and a 52-week high of $12.00. The stock has a market cap of $6.81 million, a P/E ratio of -0.26 and a beta of 1.55. The business has a fifty day moving average of $5.06 and a two-hundred day moving average of $6.61.
About Aeterna Zentaris
Featured Stories
- Five stocks we like better than Aeterna Zentaris
- How to Invest in Blue Chip Stocks
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Quiet Period Expirations Explained
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.